Daniel E. Rosan is a Consultant at The Frankel Group, a life science strategy consultancy which he joined in Fall 2009. Recently he has worked on or led teams which have:
- Assessed preclinical oncology and infectious disease technologies for a biotech client
seeking partnerships;
- Created an oncology immune therapy strategy for a global bio-pharmaceutical client;
In previous roles, Daniel has advised institutional investors, academics, non-governmental organizations, and corporations on corporate social responsibility and public health. Working with Partners in Health in Neno, Malawi while in business school, Daniel helped optimize the PIH pharmaceutical, food, and medical consumables supply chain in Malawi, increasing local purchasing and reducing costs.
As Program Director for Public Health and Access to Capital at The Interfaith Center on Corporate Responsibility (ICCR) from 2003 to 2007, Daniel coordinated HIV-TB-Malaria policy for the organization, authored primary research on pharmaceutical company HIV-TB-Malaria policy, and negotiated with company management including C-suite officers and directors. Daniel also led ICCR's response to Hurricanes Katrina and Rita, work which resulted in the launch of The Isaiah Funds LLC, an interfaith community restoration fund.
Prior to ICCR, Daniel learned community organizing in Oakland, California at the Council for Responsible Public Investment (CRPI). He has a BA in History from Vassar College and an MBA from Harvard Business School.